Eastman Chemical Company (EMN) Stock Price & Analysis
Eastman Chemical Company (EMN) closed at USD 65.31 on Thursday, October 22, 2026, up 2.85% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 65.31; the Oct 22, 2026 session ranged USD 63.1–65.55 on volume of 1,991,860 shares. Market capitalization is —, with a 52-week range of USD 56.11–83.47 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:27 UTC.
Also available as compact Markdown for AI agents: nexqual.com/EMN.md
Key facts (EMN)
- Last four reported quarters (through Jun 30, 2026): revenue $8.87B, net income $442M (5.0% margin), free cash flow $539M (SEC filings).
- 1 of 80 tracked superinvestors hold EMN (13F, Q2 2026): 0 new, 0 added, 0 reduced, 1 unchanged.
- Insider open-market sales, last ~7 months: 2 Form 4 filings, $366K; 2 not under a Rule 10b5-1 plan ($366K); 2 by opportunistic insiders (2 outside 10b5-1 plans), 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Total return with dividends: 1Y +8.7% vs S&P 500 +14.9%; 5Y -26.4% vs S&P 500 +80.3%.
- Next earnings: 2026-10-29, EPS estimate USD 1.92, revenue estimate $2.40B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (EMN)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $10.5B | $10.6B | $9.21B | $9.38B | $8.75B | $8.87B |
| Gross profit | $2.50B | $2.14B | $2.06B | $2.29B | $1.84B | — |
| Net income | $857M | $793M | $894M | $905M | $474M | $442M |
| EPS (diluted) | $6.25 | $6.35 | $7.49 | $7.67 | $4.10 | — |
| Free cash flow | $1.06B | $364M | $546M | $688M | $424M | $539M |
| Gross margin | 23.9% | 20.2% | 22.4% | 24.4% | 21.1% | — |
| Net margin | 8.2% | 7.5% | 9.7% | 9.6% | 5.4% | 5.0% |
| Revenue growth | +23.6% | +1.0% | -12.9% | +1.9% | -6.7% | — |
| Cash + short-term investments | $459M | $493M | $548M | $837M | $566M | — |
| Total debt | $5.16B | $5.15B | $4.85B | $5.02B | $4.79B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (EMN)
P/E at fiscal year-ends: Dec 2025 15.6x, Dec 2024 11.9x, Dec 2023 12.0x.
Superinvestors (SEC 13F-HR, Q2 2026) (EMN)
1 of 80 tracked investors hold EMN. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Thomas Gayner | Markel Group | 0.04% | $5.0M | Unchanged |
Insider sales (SEC Form 4, open-market, last ~7 months) (EMN)
0 of 2 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-08-04 | Holt Adrian James | SVP, Chf HR Ofcr | 3,283 | $234K | 100% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-05-05 | Holt Adrian James | SVP, Chf HR Ofcr | 1,709 | $132K | 100% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Analysts (EMN)
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-16 | JP Morgan | Downgrade | Overweight → Neutral | $82 → $66 |
| 2026-10-13 | RBC Capital | Target lowered | Sector Perform | $74 → $65 |
| 2026-10-13 | Barclays | Initiated | Equal-Weight | $72 |
| 2026-10-05 | UBS | Target lowered | Buy | $92 → $77 |
| 2026-10-01 | Mizuho | Target lowered | Outperform | $85 → $80 |
| 2026-09-30 | Citigroup | Target lowered | Buy | $81 → $76 |
| 2026-09-11 | Keybanc | Initiated | Sector Weight | |
| 2026-08-05 | RBC Capital | Target raised | Sector Perform | $69 → $74 |
| 2026-08-03 | UBS | Target raised | Buy | $89 → $92 |
| 2026-08-03 | Citigroup | Target lowered | Buy | $85 → $81 |
| 2026-07-02 | Morgan Stanley | Target lowered | Overweight | $83 → $79 |
Total return (dividends reinvested) (EMN)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +8.7% | -26.4% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +8.7% | -5.9% |
| Volatility (annualized) | 31.9% | 31.5% |
| Max drawdown | -20.9% (Feb 2026→Oct 2026) | -47.8% (Jan 2022→Jul 2025) |
EMN analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $1.92 | $1.89 | +1.3% | $2.40B | 14 |
| Next quarter (ends Dec 2026) | $1.32 | $1.45 | -8.7% | $2.17B | 14 |
| Current fiscal year (ends Dec 2026) | $6.30 | $6.28 | +0.3% | $9.24B | 16 |
| Next fiscal year (ends Dec 2027) | $6.64 | $6.87 | -3.3% | $9.41B | 16 |
Key Statistics (as of October 23, 2026 at 09:27 UTC)
| Price | USD 65.31 |
|---|---|
| Change | ▲ 2.85% (up) |
| Previous Close | USD 65.31 |
| Open | USD 65.31 |
| Day Range | USD 63.1 – 65.55 |
| 52-Week Range | USD 56.11 – 83.47 |
| Volume | 1,991,860 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (EMN)
Nexqual's technical model rates EMN "NEUTRAL" based on 2 bullish and 3 bearish signals across 127 daily candles, as of October 23, 2026 at 09:27 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 49.4 (neutral) |
| vs SMA50 | Below (USD 67.78) |
| MACD | -1.05 (negative) |
Earnings (EMN)
| Next Earnings Date | 2026-10-29 |
|---|---|
| EPS Estimate | USD 1.92 |
| Revenue Estimate | $2.40B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 1.97 vs est 1.82 ▲ beat |
| 2026-03-31 | USD 1.09 vs est 1.06 ▲ beat |
| 2025-12-31 | USD 0.75 vs est 0.72 ▲ beat |
| 2025-09-30 | USD 1.14 vs est 1.17 ▼ miss |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Financials & Fundamentals (EMN)
| Total Revenue | $8.87B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +9.90% |
| Gross Margin | +19.66% |
| Operating Margin | +12.89% |
| Profit Margin | +4.99% |
| ROE | +7.33% |
| Debt / Equity | 0.89 |
| Current Ratio | 1.5 |
| Total Cash | $693.00M |
| Total Debt | $5.47B |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $539.00M (6.1% of revenue) |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Financial Health Score (EMN)
Nexqual rates Eastman Chemical Company's overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 09:27 UTC.
| Growth | Weak — Revenue -7% YoY (annual), declining |
|---|---|
| Profitability | Mixed — Gross margin 20%, operating 13% (last 12 months) |
| Balance Sheet | Mixed — $691M cash and investments vs $5.22B debt (Jun 2026, SEC) |
| Cash Flow | Solid — FCF $539M (last 4 quarters to Jun 2026, SEC), 6% margin |
| Efficiency | Mixed — ROE 7%, ROA 3.5% |
Ownership (EMN)
| Insider Ownership | +0.93% |
|---|---|
| Institutional Ownership | +95.33% |
| Shares Outstanding | 114.33M |
| Float | 113.26M |
| Short % of Float | +7.81% |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AXTA | Axalta Coating Systems Ltd. | USD 35.05 | ▲ 0.2% |
| NEU | NewMarket Corp | USD 876.33 | ▼ 0.98% |
| ESI | Element Solutions Inc. | USD 33.11 | ▼ 8.89% |
| WLK | Westlake Corporation | USD 64.14 | ▲ 5.42% |
| SOLS | Solstice Advanced Materials Inc | USD 59.8 | ▼ 7.99% |
| SXT | Sensient Technologies Corporati | USD 130.94 | ▼ 0.95% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:27 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt